PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy
By Nigel Rawson and John Adams, November 23, 2022 For seven years, the Patented Medicines Prices Review Board (PMPRB) – ...
Tag: pharmaceutical
Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post
This article originally appeared in the Financial Post. By Nigel Rawson and John Adams, November 2, 2022 This month marks ...
Canada should stop stealing from drug companies: Richard C. Owens in the Financial Post
This article originally appeared in the Financial Post. By Richard C. Owens, July 20, 2022 In the celebrated TV drama, The ...
Reality check: Dispelling the myths around the benefits of drug price controls
By Richard C. Owens with Rebecca Rosenberg and Haya Sardar June 28, 2022 PDF of paper Executive Summary Canada’s Patented ...
Drug prices can go too low: Richard C. Owens in the Financial Post
By determinedly reducing revenues Canada not only ensures the unavailability of existing medications, it sees to it that far fewer ...
Pan-Canadian Pharmaceutical Alliance Lacks Transparency and Accountability: Nigel Rawson for Inside Policy
Negotiations to limit drug prices should not limit patients’ access to innovative drugs, writes Nigel Rawson. By Nigel Rawson, February ...
Fill in the gaps to strengthen pharmacare: Sean Speer for Inside Policy
Adopting single-payer coverage is not the solution to the challenges facing Canada’s pharmacare system, writes Sean Speer. By Sean Speer, ...
PHOTOS and VIDEO: The Best Medicine: Ensuring affordable and accessible drugs in Canada
The federal government is proposing dramatic changes to the pricing of new patented medicines in Canada, and it announced in ...
MLI Paper Calls for Stronger Intellectual Property Rules For Pharmaceuticals in Exchange for Research and Investment Commitments by Companies
MEDIA RELEASE OTTAWA June 13, 2013 - International trade negotiations with the European Union and the Trans-Pacific Partnership are creating ...
Improving Canada’s drug patent protection: Good for Canada, good for trade
In the March 2012 issue of Policy Options released by the Institute for Research on Public Policy, MLI Managing Director Brian Lee Crowley ...
MLI author Kristina Lybecker in the Windsor Star on strengthening pharmaceutical intellectual property protection
May 3, 2012 - In today's Windsor Star, MLI author Kristina Lybecker recommends changes to Canadian legislation that would help strengthen ...
MLI Paper – Modernizing Canada’s pharmaceutical patent system: An opportunity for more investment and jobs
New papers recommend changes to Canada's patent regime MEDIA RELEASE January 24, 2012, Ottawa, ON – Canada's complacency in intellectual ...
-
Democracy with Chinese characteristics
-
As NATO allies grow impatient, Canada may be quietly planning major increase in defence spending: Richard Shimooka in the Hub
-
Instead of Mulling Fox News Ban, CRTC Should Have Banned China’s CCTV by Now for Airing Forced Confession: Peter Menzies in the Epoch Times
-
All eyes on Taiwan: Preserving a hard-won liberty, the 2024 elections and beyond
-
COVID vaccine mandates in Canada were a mistake: Are we ready to learn the right lessons?
